Transurethral injection of autologous muscle precursor cells for treatment of female stress urinary incontinence: a prospective phase I clinical trial.
Saved in:
| Title: | Transurethral injection of autologous muscle precursor cells for treatment of female stress urinary incontinence: a prospective phase I clinical trial. |
|---|---|
| Authors: | Schmid FA; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Prange JA; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Kozomara M; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Betschart C; University Hospital Zurich, Department of Gynecology, University of Zurich, Zurich, Switzerland., Sousa RA; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Steinke N; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Hunziker M; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Lehner F; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Veit M; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Grossmann R; University Hospital Zurich, Clinical Trial Center, University of Zurich, Zurich, Switzerland., Landsmann A; University Hospital Zurich, Institute of Diagnostic and Interventional Radiology, University of Zurich, Zurich, Switzerland., Hötker AM; University Hospital Zurich, Institute of Diagnostic and Interventional Radiology, University of Zurich, Zurich, Switzerland., Boss A; University Hospital Zurich, Institute of Diagnostic and Interventional Radiology, University of Zurich, Zurich, Switzerland., Mohr-Haralampieva D; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland., Eberli D; University Hospital Zurich, Department of Urology, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland. daniel.eberli@usz.ch. |
| Source: | International urogynecology journal [Int Urogynecol J] 2023 Sep; Vol. 34 (9), pp. 2197-2206. Date of Electronic Publication: 2023 Apr 12. |
| Publication Type: | Clinical Trial, Phase I; Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: England NLM ID: 101567041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-3023 (Electronic) Linking ISSN: 09373462 NLM ISO Abbreviation: Int Urogynecol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
